Cargando…
A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study
Objective: Granulomatosis with polyangiitis (GPA), formerly known as Wegner’s granulomatosis, is a rare vasculitic syndrome classified under Anti-Neutrophilic Cytoplasmic Autoantibody (ANCA)-associated vasculitides, which is fatal if untreated. The mainstay of treatment consists of immunosuppression...
Autores principales: | Chaleshtori, Maryam Tavakoli, Farajzadegan, Ziba, Salesi, Mansour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176214/ https://www.ncbi.nlm.nih.gov/pubmed/35546333 http://dx.doi.org/10.5152/eurjrheum.2022.21063 |
Ejemplares similares
-
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
por: Puéchal, Xavier, et al.
Publicado: (2022) -
Unexpected Positive Effects of Rituximab and Corticosteroids on COVID-19 in a Patient Suffering from Granulomatosis with Polyangiitis
por: Salesi, Mansour, et al.
Publicado: (2021) -
Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab
por: Fujita, Yuya, et al.
Publicado: (2018) -
Eosinophilic granulomatosis with polyangiitis with severe pulmonary hemorrhage treated with rituximab
por: Baikunje, S., et al.
Publicado: (2016) -
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)